ProQR Therapeutics (PRQR) Long-Term Investments (2019 - 2021)

ProQR Therapeutics has reported Long-Term Investments for 5 years, with the latest figure at $676222.0 in Q2 2023.

• Quarterly Long-Term Investments rose 2.05% year-over-year to $676222.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $676222.0 (up 2.05% YoY) and the FY2022 annual result came in at $633573.6, up 6592.32% from the prior year.
• Long-Term Investments rose to $676222.0 in Q2 2023 per PRQR's latest filing, from $666545.3 in the prior quarter.
• Over five years, Long-Term Investments peaked at $784300.1 in Q2 2019 and troughed at $749.07 in Q1 2021.
• A 5-year average of $486013.3 and a median of $633573.6 in 2022 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2021 and 2022: Long-Term Investments slumped 99.77% in 2021, then jumped 92944.61% in 2022.
• Over 5 years, Long-Term Investments stood at $474854.8 in 2019, then sank by 73.13% to $127575.0 in 2020, then tumbled by 92.83% to $9151.8 in 2021, then jumped by 6822.96% to $633573.6 in 2022, then advanced by 6.73% to $676222.0 in 2023.
• According to Business Quant data, Long-Term Investments over the past three periods registered $676222.0, $666545.3, and $633573.6 for Q2 2023, Q1 2023, and Q4 2022 respectively.